Cell and Gene Therapy Manufacturing Market Size US $95.35 billion by 2031

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Cell and Gene Therapy Manufacturing Market Size Analysis

Global Cell and Gene Therapy Manufacturing Market Introduction
By Therapy Type
1. Introduction
  1. Therapy Type By Value
2. Cell Therapy Manufacturing
  1. By Value
3. Gene Therapy Manufacturing
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Pre-commercial/R&D Scale Manufacturing
  1. By Value
3. Commercial Scale Manufacturing
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Contract Manufacturing
  1. By Value
3. In-House Manufacturing
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Cell Processing
  1. By Value
3. Cell Banking
  1. By Value
4. Process Development
  1. By Value
5. Fill and Finish Operations
  1. By Value
6. Analytical and Quality Testing
  1. By Value
7. Raw Material Testing
  1. By Value
8. Vector Production
  1. By Value
9. Others
  1. By Value

North America Market Analysis

Introduction
By Therapy Type
1. Introduction
  1. Therapy Type By Value
2. Cell Therapy Manufacturing
  1. By Value
3. Gene Therapy Manufacturing
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Pre-commercial/R&D Scale Manufacturing
  1. By Value
3. Commercial Scale Manufacturing
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Contract Manufacturing
  1. By Value
3. In-House Manufacturing
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Cell Processing
  1. By Value
3. Cell Banking
  1. By Value
4. Process Development
  1. By Value
5. Fill and Finish Operations
  1. By Value
6. Analytical and Quality Testing
  1. By Value
7. Raw Material Testing
  1. By Value
8. Vector Production
  1. By Value
9. Others
  1. By Value
U.S.
1. By Therapy Type
  1. Introduction
    1. Therapy Type By Value
  2. Cell Therapy Manufacturing
    1. By Value
  3. Gene Therapy Manufacturing
    1. By Value
2. By Scale
  1. Introduction
    1. Scale By Value
  2. Pre-commercial/R&D Scale Manufacturing
    1. By Value
  3. Commercial Scale Manufacturing
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Contract Manufacturing
    1. By Value
  3. In-House Manufacturing
    1. By Value
4. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Cell Processing
    1. By Value
  3. Cell Banking
    1. By Value
  4. Process Development
    1. By Value
  5. Fill and Finish Operations
    1. By Value
  6. Analytical and Quality Testing
    1. By Value
  7. Raw Material Testing
    1. By Value
  8. Vector Production
    1. By Value
  9. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Therapy Type
1. Introduction
  1. Therapy Type By Value
2. Cell Therapy Manufacturing
  1. By Value
3. Gene Therapy Manufacturing
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Pre-commercial/R&D Scale Manufacturing
  1. By Value
3. Commercial Scale Manufacturing
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Contract Manufacturing
  1. By Value
3. In-House Manufacturing
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Cell Processing
  1. By Value
3. Cell Banking
  1. By Value
4. Process Development
  1. By Value
5. Fill and Finish Operations
  1. By Value
6. Analytical and Quality Testing
  1. By Value
7. Raw Material Testing
  1. By Value
8. Vector Production
  1. By Value
9. Others
  1. By Value
U.K.
1. By Therapy Type
  1. Introduction
    1. Therapy Type By Value
  2. Cell Therapy Manufacturing
    1. By Value
  3. Gene Therapy Manufacturing
    1. By Value
2. By Scale
  1. Introduction
    1. Scale By Value
  2. Pre-commercial/R&D Scale Manufacturing
    1. By Value
  3. Commercial Scale Manufacturing
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Contract Manufacturing
    1. By Value
  3. In-House Manufacturing
    1. By Value
4. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Cell Processing
    1. By Value
  3. Cell Banking
    1. By Value
  4. Process Development
    1. By Value
  5. Fill and Finish Operations
    1. By Value
  6. Analytical and Quality Testing
    1. By Value
  7. Raw Material Testing
    1. By Value
  8. Vector Production
    1. By Value
  9. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Therapy Type
1. Introduction
  1. Therapy Type By Value
2. Cell Therapy Manufacturing
  1. By Value
3. Gene Therapy Manufacturing
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Pre-commercial/R&D Scale Manufacturing
  1. By Value
3. Commercial Scale Manufacturing
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Contract Manufacturing
  1. By Value
3. In-House Manufacturing
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Cell Processing
  1. By Value
3. Cell Banking
  1. By Value
4. Process Development
  1. By Value
5. Fill and Finish Operations
  1. By Value
6. Analytical and Quality Testing
  1. By Value
7. Raw Material Testing
  1. By Value
8. Vector Production
  1. By Value
9. Others
  1. By Value
China
1. By Therapy Type
  1. Introduction
    1. Therapy Type By Value
  2. Cell Therapy Manufacturing
    1. By Value
  3. Gene Therapy Manufacturing
    1. By Value
2. By Scale
  1. Introduction
    1. Scale By Value
  2. Pre-commercial/R&D Scale Manufacturing
    1. By Value
  3. Commercial Scale Manufacturing
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Contract Manufacturing
    1. By Value
  3. In-House Manufacturing
    1. By Value
4. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Cell Processing
    1. By Value
  3. Cell Banking
    1. By Value
  4. Process Development
    1. By Value
  5. Fill and Finish Operations
    1. By Value
  6. Analytical and Quality Testing
    1. By Value
  7. Raw Material Testing
    1. By Value
  8. Vector Production
    1. By Value
  9. Others
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Therapy Type
1. Introduction
  1. Therapy Type By Value
2. Cell Therapy Manufacturing
  1. By Value
3. Gene Therapy Manufacturing
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Pre-commercial/R&D Scale Manufacturing
  1. By Value
3. Commercial Scale Manufacturing
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Contract Manufacturing
  1. By Value
3. In-House Manufacturing
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Cell Processing
  1. By Value
3. Cell Banking
  1. By Value
4. Process Development
  1. By Value
5. Fill and Finish Operations
  1. By Value
6. Analytical and Quality Testing
  1. By Value
7. Raw Material Testing
  1. By Value
8. Vector Production
  1. By Value
9. Others
  1. By Value
UAE
1. By Therapy Type
  1. Introduction
    1. Therapy Type By Value
  2. Cell Therapy Manufacturing
    1. By Value
  3. Gene Therapy Manufacturing
    1. By Value
2. By Scale
  1. Introduction
    1. Scale By Value
  2. Pre-commercial/R&D Scale Manufacturing
    1. By Value
  3. Commercial Scale Manufacturing
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Contract Manufacturing
    1. By Value
  3. In-House Manufacturing
    1. By Value
4. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Cell Processing
    1. By Value
  3. Cell Banking
    1. By Value
  4. Process Development
    1. By Value
  5. Fill and Finish Operations
    1. By Value
  6. Analytical and Quality Testing
    1. By Value
  7. Raw Material Testing
    1. By Value
  8. Vector Production
    1. By Value
  9. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Therapy Type
1. Introduction
  1. Therapy Type By Value
2. Cell Therapy Manufacturing
  1. By Value
3. Gene Therapy Manufacturing
  1. By Value
By Scale
1. Introduction
  1. Scale By Value
2. Pre-commercial/R&D Scale Manufacturing
  1. By Value
3. Commercial Scale Manufacturing
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Contract Manufacturing
  1. By Value
3. In-House Manufacturing
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Cell Processing
  1. By Value
3. Cell Banking
  1. By Value
4. Process Development
  1. By Value
5. Fill and Finish Operations
  1. By Value
6. Analytical and Quality Testing
  1. By Value
7. Raw Material Testing
  1. By Value
8. Vector Production
  1. By Value
9. Others
  1. By Value
Brazil
1. By Therapy Type
  1. Introduction
    1. Therapy Type By Value
  2. Cell Therapy Manufacturing
    1. By Value
  3. Gene Therapy Manufacturing
    1. By Value
2. By Scale
  1. Introduction
    1. Scale By Value
  2. Pre-commercial/R&D Scale Manufacturing
    1. By Value
  3. Commercial Scale Manufacturing
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Contract Manufacturing
    1. By Value
  3. In-House Manufacturing
    1. By Value
4. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Cell Processing
    1. By Value
  3. Cell Banking
    1. By Value
  4. Process Development
    1. By Value
  5. Fill and Finish Operations
    1. By Value
  6. Analytical and Quality Testing
    1. By Value
  7. Raw Material Testing
    1. By Value
  8. Vector Production
    1. By Value
  9. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Cell and Gene Therapy Manufacturing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Lonza
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Catalent Inc.
Samsung Biologics
Cellular Therapeutics
Boehringer Ingelheim
Hitachi Chemical Co., Ltd.
Hoffmann-La Roche Ltd.
Bluebird Bio Inc.
Takara Bio Inc.
Miltenyi Biotec
Thermo Fisher Scientific
Novartis AG
Merck KGaA
Wuxi Advanced Therapies

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment